Methods for the production of proteins with a desired function

• US 5,627,052 A
• Filed: 06/05/1995
• Issued: 05/06/1997
• Est. Priority Date: 08/02/1990
• Status: Expired due to Term

• Current Assignee: Abgenix Biopharma Incorporated (Amgen Inc.)
• Original Assignee: BR Centre Limited
• Inventors: Schrader, John W.
• Primary Examiner(s): Feisee, Lila
• Assistant Examiner(s): Reeves, Julie E.
• Application Number:
  US08/464,261
• Time in Patent Office: 701 Days
• Field of Search: 530/387.1, 530/388.24, 435/70.21, 435/172.3, 435/69.6
• US Class Current: 435/69.6
• CPC Class Codes: C07K 16/00 Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies antibodies with enzymatic activity, e.g. abzymes C12N9/0002
• CPC Class Codes: C07K 16/246 IL-2
• CPC Class Codes: C07K 16/28 against receptors, cell surface antigens or cell surface determinants

Abstract

The present invention provides a method for producing proteins with a desired function, generally comprising the steps of (a) providing a population of antibody-forming cells suspected of containing at least one cell capable of producing an antibody exhibiting a desired function; (b) suspending the population of antibody-forming cells in a medium, the medium having an indicator system incorporated therein, the indicator system also being capable of indicating the presence and location of a cell which forms antibodies exhibiting the desired function; (c) identifying a cell forming an antibody exhibiting the desired function; (d) isolating the identified antibody-forming cell from the medium; (e) determining the amino acid sequence of the variable region or a portion thereof which coffers the desired function of the antibody produced by the isolated antibody-forming cell; and (f) synthesizing a protein with a desired function, the protein containing the amino acid sequence of the variable region or portion thereof which confers the desired function.

Claims

1. A method for producing an antibody, antibody variable region, or a portion thereof which has an antibody binding region with a desired function, comprising:

(a) obtaining from a warm-blooded animal a population of antibody-forming B cells or antibody-forming progeny thereof wherein the B cells or progency thereof are non-hybridoma or non-Epstein Barr virus (EBV) transformed, and wherein the B cells or progency thereof contain at least one cell that produces an antibody exhibiting a desired function, followed by;

(b) suspending the population of antibody-forming B cells or progency thereof in a medium, the medium having an indicator system incorporated therein which indicates the presence and location of a cell which forms antibodies exhibiting the desired function;

(c) identifying a cell forming an antibody exhibiting the desired function;

(d) isolating the identified antibody-forming cell from the medium;

(e) determining the amino acid sequence of the variable region or a portion thereof which exhibits the desired function of the antibody produced by the isolated antibody-forming cell; and

(f) synthesizing an antibody, antibody variable region, or a portion thereof which has the amino acid sequence of the variable region or portion thereof which exhibits the desired function.

3. The method of claims 1 or 2 including, subsequent to the step of isolating the antibody-forming cell:

(a) recovering RNA from said isolated antibody-forming cell;

(b) generating cDNA from said RNA; and

(c) amplifying the cDNA of the variable region or a portion thereof which confers the desired function of the antibody produced by the isolated antibody-forming cell.

4. The method of claims 1 or 2 including, subsequent to the step of isolating the antibody-forming cell:

(a) recovering RNA from said isolated antibody-forming cell;

(b) amplifying the RNA of the variable region or a portion thereof which confers the desired function of the antibody produced by the isolated antibody-forming cell; and

(c) generating cDNA from said RNA.

5. The method of claims 1 or 2 including, subsequent to the step of isolating the antibody-forming cell:

(a) recovering DNA from said isolated antibody-forming cell; and

(b) amplifying the DNA of the variable region or a portion thereof which confers the desired function of the antibody produced by the isolated antibody-forming cell.

8. The method of claims 1, 2, 6, or 7 wherein said medium is selected from the group consisting of a layer of gelified media and a layer of liquid media.

9. The method of claim 8 wherein the medium is a nutrient medium.

10. The method of claim 8 wherein the gelified media comprises about 0.3% to 0.6% agar or about 1.0% methyl cellulose.

11. The method of claims 1, 2, 6, or 7 wherein the antibody-forming B cells or progeny thereof are obtained from an animal which has been immunized with a selected antigen.

12. The method of claim 11 wherein the antigen is selected from the group consisting of erythropoietin, erythropoietin receptors, colony-stimulating factors, and viral antigens.

13. The method of claims 1, 2, 6, or 7 wherein the antibody-forming B cells or progeny thereof are obtained from an animal which generated said cells during the course of a selected disease.

14. The method of claims 1, 2, 6, or 7 wherein said animal is a warm-blooded animal selected from the group consisting of rabbits, humans, mice, rats, sheep, cows, and pigs.

15. The method of claims 1, 2, 6, or 7, including, subsequent to the step of isolating an identified antibody-forming cell, enriching the population of antibody-forming cells by exposure to bovine serum albumin or Percoil gradient.

16. The method of claims 1, 2, 6, or 7 wherein the indicator system comprises a layer of cells whose growth, viability, or function is affected by antibodies exhibiting a desired function produced by the isolated antibody-forming cell.

17. The method of claims 1, 2, 6, or 7 wherein the antibody which exhibits a desired function exhibits biological activity analogous to a protein selected from the group consisting of IL-1α

, IL-1β

, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IFN-α

, IFNγ

, G-CSF, M-CSF, GM-CSF, TNF-α

, TGFβ

, erythropoietin, EGF, PDGF, and the ligand of the kit protein.

18. The method of claims 1, 2, 6, or 7 wherein the indicator system comprises one or more pathogenic microorganisms, and a layer of cells susceptible to infection by said microorganisms, wherein said antibodies exhibiting a desired function are identified as those which effect the pathogenicity of the microorganism.

19. The method of claim 18 wherein the layer of cells is adhered to a glass slide or petri dish.

20. The method of claims 1, 2, 6, or 7 wherein the indicator system comprises a set of two cell types selected from the group consisting of cells of distinct HLA histocompatibility antigen types, blood group antigen types, and tumor cells and normal cells of the same lineage, wherein said antibodies exhibiting a desired function are identified as those which agglutinate or lyse one cell of the two cell types.

21. The method of claim 20 wherein one of said cell types is labeled.

22. The method of claims 1, 2, 6, or 7 wherein the indicator system comprises erythrocytes or other particles coated with antigen, and said antibody exhibiting a desired function is identified as that which binds to the antigen, thereby causing the particles to agglutinate.

23. The method of claims 1, 2, 6, or 7 wherein the indicator system comprises erythrocytes or other particles coated with antigen, and said antibody exhibiting a desired function is identified as that which binds to the antigen, lysing the cells or particles in the presence of complement.

24. The method of claim 23 wherein the erythrocytes or other particles are coated with antigen utilizing a biotin/avidin coupling system.

25. The method of claim 23 wherein the indicator system further comprises anti-immunoglobulin antibodies such that complement fixation is enhanced.

26. The method of claims 1, 2, 6, or 7 wherein the indicator system comprises a complexing factor, and said antibody-forming cell is identified as that which binds to the complexing factor, forming a rosette.

27. The method of claim 26 wherein the complexing factor is an erythrocyte coupled to an antigen.

28. The method of claim 26 wherein the complexing factor is a particle coupled to an antigen.

29. The method of claim 26 wherein the complexing factor is a microorganism.

30. The method of claims 1, 2, 6, or 7 wherein the indicator system comprises a substrate, and said antibody exhibiting a desired function is identified as that which modifies the substrate in a detectable manner.

31. The method of claim 30 wherein the substrate is a chromogenic substrate, and wherein said chromogenic substrate is modified to produce a detectable color change in the vicinity of the antibody-forming cell.

32. The method of claim 30 wherein the substrate is a fluorogenic substrate, wherein said fluorogenic substrate is modified to produce a detectable change in fluorescence in the vicinity of the antibody-forming cell.

33. The method of claim 30 wherein the substrate is a colored substrate, wherein said colored substrate is modified to produce a detectable loss of color in the vicinity of the antibody-forming cell.

34. The method of claim 30 wherein the substrate is a fluorescent substrate, and wherein said fluorescent substrate is modified to produce a detectable loss of fluorescence in the vicinity of the antibody-forming cell.

35. The method of claim 30 wherein the antibody exhibiting a desired function cleaves the substrate, the product of this reaction allowing the detection of said antibody upon the addition of a reagent selected from the group consisting of stains, and, labeled antibodies.

36. The method of claim 30 wherein the substrate is a precursor of the hemolytic toxin aerolysin and wherein said antibody exhibiting a desired function is identified as that which cleaves said precursor, thus activating the toxin.

37. The method of claims 1, 2, 6 or 7 wherein the indicator system is positioned contiguous to the medium.

38. The method according to any one of claims 1, 2, 6 or 7, further comprising, prior to the step of obtaining a population of non-hybridoma antibody forming cells, immunizing a warm-blooded animal with a selected antigen.

2. A method for producing an antibody, antibody variable region, or a portion thereof which has an antibody binding region with a desired function, comprising:

(a) obtaining from a warm-blooded animal a population of antibody-forming B cells or antibody-forming progeny thereof, wherein the B cells or progeny thereof are non-hybridoma or non-EBV transformed, and wherein the B cells or progeny thereof contain at least one cell that produces an antibody exhibiting a desired function, followed by;

(b) suspending the population of antibody-forming B cells or progeny thereof in a medium, the medium having all indicator system incorporated therein which indicates, the presence and location of a cell which forms antibodies exhibiting the desired function;

(c) identifying a cell forming an antibody exhibiting the desired function;

(d) isolating the identified antibody-forming cell from the medium;

(e) determining the amino acid sequence of the variable region or a portion thereof which exhibits the desired function of the antibody produced by the isolated antibody-forming cell;

(f) incorporating the DNA sequence corresponding to the amino acid sequence of said variable region or portion thereof conferring the desired function into a vector which directs the expression and secretion of said antibody, antibody variable region, or a portion thereof which has an antibody binding region with a desired function;

(g) transletting said vector into a host cell;

(h) growing said host cells in an appropriate medium; and

(i) isolating the antibody, antibody variable region, or a portion thereof which has an antibody binding region with the desired function.

6. A method for producing an antibody, antibody variable region, or a portion thereof which has an antibody binding region with a desired function, comprising:

(a) obtaining from a warm-blooded animal a population of antibody-forming B cells or antibody-forming progeny thereof, wherein the B cells or progeny thereof are non-hybridoma or non-EBV transformed, and wherein the B cells or progeny thereof contain at least one cell that produces an antibody exhibiting a desired function;

followed by

(b) suspending the population of antibody-forming B cells or progeny thereof in a medium, the medium having an indicator system incorporated therein which indicates the presence and location of a cell which forms antibodies exhibiting the desired function;

(c) identifying a cell forming an antibody exhibiting the desired function;

(d) isolating the identified antibody-forming cell from the medium;

(e) recovering RNA from said isolated antibody-forming cell;

(f) generating cDNA from said RNA;

(g) amplifying the cDNA of the variable region or a portion thereof which confers the desired function of the antibody produced by the isolated antibody-forming cell;

(h) incorporating the amplified cDNA into a vector capable of directing the expression and secretion of an antibody, antibody variable region, or a portion thereof which has an antibody binding region with the desired function;

(i) transfecting said vector into a host cell;

(j) growing said host cells in an appropriate medium; and

(k) isolating the antibody, antibody variable region, or a portion thereof which has an antibody binding region with the desired function from said host cell.

7. A method for producing an antibody, antibody variable region, or a portion thereof which has an antibody binding region with a desired function, comprising:

(a) obtaining from a warm-blooded animal a population of antibody-forming B cells or anti-forming progeny thereof, wherein the B cells or progeny thereof are non-hybridoma or non-EBV transformed, and wherein the B cells or progeny thereof contain at least one cell that produces an antibody exhibiting a desired function, followed by;

(b) suspending the population of antibody-forming B cells or progeny thereof in a medium, the medium having an indicator system incorporated therein which indicates the presence and location of a cell which forms antibodies exhibiting the desired function;

(c) identifying a cell forming an antibody exhibiting the desired function;

(d) isolating the identified antibody-forming cell from the medium;

(e) recovering RNA from said isolated antibody-forming cell;

(f) amplifying the RNA of the variable region or a portion thereof which confers the desired function of the antibody produced by the isolated antibody-forming cell;

(g) generating cDNA from said RNA;

(h) incorporating the cDNA into a vector capable of directing the expression and secretion of an antibody, antibody variable region, or a portion thereof which has an antibody binding region with the desired function;

(i) transfecting said vector into a host cell;

(j) growing said host cells in an appropriate medium; and

(k) isolating the antibody, antibody variable region, or a portion thereof which has an antibody binding region with the desired function from said host cell.